Evaluation of Automated Laser-Assisted Tattoo Removal: a Prospective Feasibility Clinical Study
1 other identifier
interventional
10
1 country
1
Brief Summary
The goal of this study is to collect preliminary clinical performance data focused on the usability aspects of the human - machine interaction, with focus on planning, navigation and application of automated laser tattoo removal. The study will enroll adult patients with monochrome dark tattoos. In addition to the data collected on the human-machine interaction, it will also collect other outcomes like pain during treatment, overall user and patient satisfaction, and adverse events. For the participants, treatment will follow standard procedures. In addition to this, they will be followed up after 30 days, to see if any complications occured.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2026
CompletedFirst Posted
Study publicly available on registry
August 11, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2026
Study Completion
Last participant's last visit for all outcomes
November 30, 2026
August 11, 2026
August 1, 2026
3 months
February 10, 2026
August 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
•VAS for defining target region, region of therapy, clarity and degree of completion of projection of region of therapy on patient skin
Directly after treatment
•VAS for usefulness of indication of size of region of therapy
Directly after treatment
• Y/N for laser path assessment
Directly after treatment
• # for number of unintended interruptions
Directly after treatment
Secondary Outcomes (6)
• Time required in minutes
Directly after treatment
• VAS for assessing pain score
Directly after treatment
• VAS for assessing ease of communication through user interface
Directly after treatment
• VAS for assessing overall user and patient satisfaction
Directly after treatment
• Collection of data on Adverse Events
Up to 30 days after treatment
- +1 more secondary outcomes
Study Arms (1)
Tattoo and Permanent Make-Up Removal
EXPERIMENTALInterventions
The investigational device, PiRAT, uses a standard laser, but with added automation which has the potential to perform the procedure more quickly and precisely, with less heat accumulation and less documentation required. observed, documented, and assessed in real-life circumstances.Documentation of patient / skin data
Eligibility Criteria
You may qualify if:
- Adults (18 - 84 years)
- Woman or man (for women in their reproductive age, a confirmation of a pregnancy test with negative result is mandatory)
- Fitzpatrick skin types I-VI
- Monochrome dark tattoo (black, dark grey, dark blue, dark green, dark red, puce)
- Tattoo size ≤ A5 (311 cm2)
You may not qualify if:
- Patients with absolute or relative contraindications (according to IFU)
- Pregnancy or breastfeeding
- History of keloids or hypertrophic scarring
- Active skin infections or conditions at the tattoo site
- Use of photosensitizing medications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Raylution AGlead
Study Sites (1)
Re.Naissance
Basel, Canton of Basel-City, 4056, Switzerland
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2026
First Posted
August 11, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
August 11, 2026
Record last verified: 2026-08